NCT06251661

Brief Summary

This interventional study aims to investigate the therapeutic efficacy of Cognitive multi-sensory rehabilitation (CMR) on upper limb function and fatigue in chronic stroke patients. The main question is: • Does cognitive multi-sensory rehabilitation significantly affect upper limb function and fatigue in stroke patients? Participants will be assigned into two groups. They will receive 12 sessions of study group CMR and traditional physical therapy and control group traditional physical Therapy rehabilitation. CMR 40 minutes immediately followed by 20 minutes of selected physical therapy program, three sessions per week for four weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2023

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

February 1, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 9, 2024

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2024

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2024

Completed
Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

1 year

First QC Date

February 1, 2024

Last Update Submit

January 17, 2026

Conditions

Keywords

CMRStrokeupper limb functionfatigue

Outcome Measures

Primary Outcomes (4)

  • Fugl-Meyer Assessment for upper extremity (FMT-UE).

    Changes in upper limb function.

    from baseline to four weeks after the beginning of intervention

  • Serum levels of Brain-Derived Neurotrophic Factor (BDNF)

    Changes in serum levels of neural plasticity factors

    from baseline to four weeks after the beginning of intervention

  • Changes in hand grip strength

    Hand grip strength was measured by an electronic hand dynamometer device.

    from baseline to four weeks after the beginning of intervention

  • Fatigue Assessment Scale (FAS)

    determine the degree of self-reported fatigue in daily living activities. Each item of the FAS is answered using a fi ve-point, Likert-type scale ranging from 1 ("never") to 5 ("always"). Items 4 and 10 are reverse-scored. Total scores can range from 10, indicating the lowest level of fatigue, to 50, denoting the highest.

    from baseline to four weeks after the beginning of intervention

Secondary Outcomes (1)

  • Box and Blocks Test (BBT)

    from baseline to four weeks after beginning of the intervention.

Study Arms (2)

Group 1 (GA)

ACTIVE COMPARATOR

20 Egyptian ischemic stroke patients receive 12 sessions of CMR and traditional physical therapy each session lasts for 40 minutes of CMR and 30 minutes of traditional physical therapy.

Other: Cognitive multi-sensory RehabilitionOther: selected traditional physical therapy program.

Group 2 (GB)

SHAM COMPARATOR

20 Egyptian ischemic stroke patients receive 12 sessions of traditional physical therapy each session lasts for 30 minutes.

Other: selected traditional physical therapy program.

Interventions

Kinetic awareness: Initially, only one joint will be moved at a time. Then the therapist will reposition the joint and ask the participants to report their perception of the joint position. Initially, the participants will distinguish between just two positions. If they reliably answer correctly, increase up to five points and integrate speed and dexterity in functional movements. Participants will be asked to relax and feel the movement during this training. Discrimination exercise: The therapist places a part of the participant's limb, the fingertip, on an external object (a block) and the participant will be asked to actively move his or her limb over the object and try to sense the shape of the object. If the participants differentiate between the two objects, then increase the number of objects (up to five). Functional training: The patient reaches toward many objects functionally (cup, ball, cane) from different angles, holds them, and relocates them again.

Group 1 (GA)

The selected physical therapy program session will be occupational therapy training for the hand, strengthening exercises for the weak upper limb stretching exercises for short upper limb muscles, balance exercise, and gait training.

Group 1 (GA)Group 2 (GB)

Eligibility Criteria

Age45 Years - 65 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsThe study will be applied to ischemic stroke. This type of stroke is more common in males than females because most smokers are males. As known, smoking is the major cause of ischemic stroke due to atherosclerotic changes in cerebral blood vessels.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 45 and 65 years.
  • months after ischemic stroke
  • living in the community (i.e., not in a long-term care home).
  • medically stable.
  • normal score in the Montreal Cognitive Assessment (MoCA: 25 to 30, maximum score = 30).
  • Spasticity of upper limb muscles ranged from (grade 1:2) according to the Modified Ashworth scale.

You may not qualify if:

  • severe spasticity (Modified Ashworth Scale score of 4)
  • any medical condition that hinders full participation,
  • another neurological diagnosis beyond stroke including cognitive impairment, or
  • upper extremity pain \> 4/10 on the Numeric Pain Rating Scale (maximum 10/10).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy Cairo University

Cairo, Giza Governorate, 12612, Egypt

Location

MeSH Terms

Conditions

StrokeIschemiaFatigue

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Nahed Salem, professor

    Cairo University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer Assistant

Study Record Dates

First Submitted

February 1, 2024

First Posted

February 9, 2024

Study Start

February 1, 2023

Primary Completion

February 14, 2024

Study Completion

February 28, 2024

Last Updated

January 21, 2026

Record last verified: 2026-01

Locations